Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2023, 5(12); doi: 10.25236/FMSR.2023.051205.

The expression of SFRP2 in gastric cancer and its mechanism of inhibiting gastric cancer invasion and metastasis

Author(s)

Hao Zhao1, Xie Li2, Wu Yingying1

Corresponding Author:
Wu Yingying
Affiliation(s)

1Department of Oncology, The Second Naval Hospital of the Southern Theater Command of PLA, Sanya, China

2Department of Anesthesiology, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, China

Abstract

To investigate the effects and mechanisms of SFRP2 on the proliferation and invasion of human gastric cancer cell line BGC823, gastric cancer cell line BGC823 was used, which was resuscitated by liquid nitrogen, added with DMEM medium (containing 10% fetal bovine serum and 1% penicillin-streptomycin), and cultured at 37 ℃ with 5% CO2. When the cell attachment rate exceeded 80%, three passages were performed. The blank control plasmid pc-DNA and SFRP2 overexpression plasmid were transfected with Lipo-fectamine 2000 reagent. BGC823 cells in logarithmic growth phase were divided into control group, blank plasmid group and SFRP2 overexpression group. The cells in each group were cultured for 24 hours, and the proliferation of the cells in each group was detected by MTT assay and clone formation assay. The expression of E-cadherin, β-catenin and SFRP2 was detected by Western blot. The results showed that the proliferative activity of cells in the SFRP2 overexpression group was significantly lower than that of cells in the control and blank plasmid groups (P<0 05); there was no significant difference in the proliferative activity of cells in the control and blank plasmid groups. The numbers of cell clones in the control, blank plasmid and SFRP2 overexpression groups were (255.69 ± 29.71), (243.18 ± 5.82) and (178.28 ± 23.42), respectively; among them, the number of cell clones in the SFRP2 overexpression group was significantly lower than that of the control group and the blank plasmid group (P<0 05).The relative numbers of E-cadherin The relative expression of E-cadherin and SFRP 2 proteins in the SFRP 2 overexpression group was significantly higher than that in the control and blank plasmid groups (P<0.05), and the relative expression of β-catenin protein in the SFRP 2 overexpression group was significantly lower than that in the control and blank plasmid groups (P<0.05). Cells in each experimental group were detected by Transwell invasion assay. The results showed that the number of cells in the SFRP 2 overexpression group was significantly lower than that in the control group and the blank plasmid group (P < 0. 05), and there was no significant difference between the control group and the blank plasmid group.SFRP2 protein can inhibit the WNT pathway and inhibit the occurrence and invasion and metastasis of gastric cancer EMT.

Keywords

Gastric cancer, SFRP2, E-cadherin, WNT pathway, EMT

Cite This Paper

Hao Zhao, Xie Li, Wu Yingying. The expression of SFRP2 in gastric cancer and its mechanism of inhibiting gastric cancer invasion and metastasis. Frontiers in Medical Science Research (2023) Vol. 5, Issue 12: 43-48. https://doi.org/10.25236/FMSR.2023.051205.

References

[1] Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians, 71(3), 209–249. https://doi.org/ 10.3322/caac.21660

[2] Roth W, Wild-Bode C, Platten M, Grimmel C, Melkonyan HS, Dichgans J, Weller M. Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene 2000; 19: 4210-20.

[3] Jia Y, Yang Y, Brock MV, Zhan Q, Herman JG, Guo M. Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer. The Journal of pathology 2013;230: 194-204.

[4] Bartfeld S, Bayram T, van de Wetering M, Huch M, Begthel H, Kujala P, Vries R, Peters PJ, Clevers H. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology 2015; 148: 126-136 e6.

[5] Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139(5):871-890.

[6] Mirotsou M, Zhang Z, Deb A, Zhang L, Gnecchi M, Noiseux N, Mu H, Pachori A, Dzau V. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proceedings of the National Academy of Sciences of the United States of America. 2007 Jan 30;104(5):1643-1648.

[7] Xiao X, Xiao Y, Wen R, Zhang Y, Li X, Wang H, Huang J, Liu J, Long T, Tang J. Promoting roles of the secreted frizzled-related protein 2 as a Wnt agonist in lung cancer cells. Oncology reports 2015 Nov;34(5):2259-2266.

[8] Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nature reviews Cancer. 2008 May;8(5):387-398.

[9] Uematsu K, He B, You L, Xu Z, McCormick F, Jablons DM. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene. 2003 Oct 16;22(46):7218-7221.

[10] Clevers H, Batlle E. EphB/EphrinB receptors and Wnt signaling in colorectal cancer. Cancer research 2006; 66: 2-5.

[11] Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, Trent JM. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell. 2002 Apr;1(3):279-288.

[12] Aly RM, Taalab MM, Abdsalam EM. Prognostic Significance of Secreted Frizzled-Related Protein 2 Expression in Cytogenetically Normal Primary Acute Myeloid Leukemia. Am J Med Sci. 2015 Nov;350(5):369-373.

[13] Chung MT, Lai HC, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, Liu HS, Chu DW, Lin YW. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Gynecol Oncol. 2009 Mar;112(3):646-653.

[14] Xiao C, Wang L, Zhu L, Zhang C, Zhou J. Secreted frizzled related protein 2 is epigenetically silenced and functions as a tumor suppressor in oral squamous cell carcinoma. Mol Med Rep. 2014 Nov;10(5):2293-2298.